AI Terminal
Assura PLC
Director's Dealing • Jul 12, 2024
4924_dirs_2024-07-12_8e414d7d-77c1-4545-a59b-ac48c83e6728.html
Director's Dealing
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information 
RNS Number : 2293W
Assura PLC
12 July 2024
12 July 2024
Assura plc
("the Company")
Notification of transaction by Persons Discharging Managerial Responsibilities ("PDMRs") and connected persons
Assura plc ("Assura"), the specialist healthcare property investor and developer announces that on 8 July 2024, the following named PDMRs were granted the following share options over Ordinary Shares of 10 pence each in the Company under the Company's Performance Share Plan ("PSP").
| PDMR | Position | Number of Share Options Granted |
| Jonathan Murphy | CEO | 1,905,505 |
| Jayne Cottam | CFO | 1,269,599 |
These options are subject to three performance conditions which will be determined after the 2026/27 financial year. 33% of the option shares are subject to a Total Shareholder Return ("TSR") performance condition, 33% of the option shares are subject to a Total Accounting Return ("TAR") performance condition and the remaining 33% are subject to ESG measures related to portfolio energy reduction targets (energy usage intensity, "EUI") and net zero carbon developments. Details of the performance conditions are set out in the Company's Directors' Remuneration Report for 2023/24.
In addition, the following PDMRs were granted restricted share options over Ordinary Shares of 10 pence each in the company under the PSP.
| PDMR | Position | Number of Restricted Share Options Granted |
| Orla Ball | General Counsel | 88,474 |
| Robert James | Group Development Director | 88,474 |
| Sarah Taylor | Chief People Officer | 88,474 |
The Notification of Dealing Forms can be found below.
This notification is made in accordance with the Market Abuse Regulation.
Notification of dealing form
1
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
Jonathan Murphy
2
Reason for the notification
a)
Position/status
CEO
b)
Initial notification/ Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Assura plc
b)
LEI
21380026T19N2Y52XF72
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Share options over ordinary shares of 10 pence each
GB00BVGBWW93
b)
Nature of the transaction
Grant of options under the PSP
c)
Price(s) and volume(s)
| Price(s) | Volume(s) |
| £NIL GBP | 1,905,505 |
d)
Aggregated information
- Aggregated volume
- Price
| Aggregate Price | Aggregate Volume | Aggregate Total |
| £NIL GBP | 1,905,505 | £NIL GBP |
e)
Date of the transaction
08/07/2024
f)
Place of the transaction
XLON
1
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
Jayne Cottam
2
Reason for the notification
a)
Position/status
CFO
b)
Initial notification/ Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Assura plc
b)
LEI
21380026T19N2Y52XF72
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Share options over ordinary shares of 10 pence each
GB00BVGBWW93
b)
Nature of the transaction
Grant of options under the PSP
c)
Price(s) and volume(s)
| Price(s) | Volume(s) |
| £NIL GBP | 1,269,599 |
d)
Aggregated information
- Aggregated volume
- Price
| Aggregate Price | Aggregate Volume | Aggregate Total |
| £NIL GBP | 1,269,599 | £NIL GBP |
e)
Date of the transaction
08/07/2024
f)
Place of the transaction
XLON
1
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
Orla Ball
2
Reason for the notification
a)
Position/status
General Counsel
b)
Initial notification/ Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Assura plc
b)
LEI
21380026T19N2Y52XF72
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Share options over ordinary shares of 10 pence each
GB00BVGBWW93
b)
Nature of the transaction
Grant of restricted share options under the PSP
c)
Price(s) and volume(s)
| Price(s) | Volume(s) |
| £NIL GBP | 88,474 |
d)
Aggregated information
- Aggregated volume
- Price
| Aggregate Price | Aggregate Volume | Aggregate Total |
| £NIL GBP | 88,474 | £NIL GBP |
e)
Date of the transaction
08/07/2024
f)
Place of the transaction
XLON
1
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
Robert James
2
Reason for the notification
a)
Position/status
Group Development Director
b)
Initial notification/ Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Assura plc
b)
LEI
21380026T19N2Y52XF72
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Share options over ordinary shares of 10 pence each
GB00BVGBWW93
b)
Nature of the transaction
Grant of restricted share options under the PSP
c)
Price(s) and volume(s)
| Price(s) | Volume(s) |
| £NIL GBP | 88,474 |
d)
Aggregated information
- Aggregated volume
- Price
| Aggregate Price | Aggregate Volume | Aggregate Total |
| £NIL GBP | 88,474 | £NIL GBP |
e)
Date of the transaction
08/07/2024
f)
Place of the transaction
XLON
1
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
Sarah Taylor
2
Reason for the notification
a)
Position/status
Chief People Officer
b)
Initial notification/ Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Assura plc
b)
LEI
21380026T19N2Y52XF72
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Share options over ordinary shares of 10 pence each
GB00BVGBWW93
b)
Nature of the transaction
Grant of restricted share options under the PSP
c)
Price(s) and volume(s)
| Price(s) | Volume(s) |
| £NIL GBP | 88,474 |
d)
Aggregated information
- Aggregated volume
- Price
| Aggregate Price | Aggregate Volume | Aggregate Total |
| £NIL GBP | 88,474 | £NIL GBP |
e)
Date of the transaction
08/07/2024
f)
Place of the transaction
XLON
- Ends -
For more information, please contact:
| Assura plc | Tel: 0161 515 2043 |
| Orla Ball, G eneral Counsel David Purcell, Investor Relations Director |
Email: [email protected] |
| FGS Global Gordon Simpson Grace Whelan |
Tel: 0207 251 3801 Email: [email protected] |
Notes to Editors
Assura plc is the UK's leading specialist healthcare property investor and developer. Assura enables better health outcomes through its portfolio of more than 600 healthcare buildings, from which over six million patients are served.
A UK REIT based in Altrincham, Assura is a constituent of the FTSE 250 and the EPRA* indices. As at 31 March 2024, Assura's portfolio was valued at £2.7 billion and has a strong track record of growing financial returns and dividends for shareholders.
At Assura, we BUILD for health, having developed over 100 new healthcare buildings in our history, and at the heart of our strategy sits The Bigger Picture; Healthy Environment (E), Healthy Communities (S), Healthy Business (G).
Further information is available at www.assuraplc.com
*EPRA is a registered trademark of the European Public Real Estate Association.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHGCGDRXGBDGSD